Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synthetic MR ABXSAT:SYNT +1.32%63 Altman Z-Score is 0.60 as of Jul. 14, 2026, which is 99% below its 10-year median of 59.35. GuruFocus rates XSAT:SYNT with a GF Score™ of 63/100 and a GF Value™ of kr4.59 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 660 Healthcare Providers & Services companies, Synthetic MR AB ranks worse than 79.7% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 0.59 is in distress zone. This implies bankruptcy possibility in the next two years.
Synthetic MR AB has a Altman Z-Score of 0.60, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Synthetic MR AB's Altman Z-Score or its related term are showing as below:
XSAT:SYNT'
s Altman Z-Score Range Over the Past 10 Years
Min: 0.59 Med: 59.35 Max: 163.41
Current: 0.59
During the past 13 years, Synthetic MR AB's highest Altman Z-Score was 163.41. The lowest was 0.59. And the median was 59.35.
Synthetic MR AB (XSAT:SYNT) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Synthetic MR AB Altman Z-Score Related Terms
Synthetic MR AB Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Synthetic MR AB's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:SYNT vs VEEV, BTSG, TEM: Altman Z-Score Comparison
For the Health Information Services subindustry, Synthetic MR AB's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synthetic MR AB Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Synthetic MR AB's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Synthetic MR AB's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.3419
+
1.4
*
-0.2055
+
3.3
*
-0.2776
+
0.6
*
1.7488
+
1.0
*
0.3434
=
0.60
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Synthetic MR AB (XSAT:SYNT) has a Altman Z-Score of 0.60 as of Jul. 14, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Synthetic MR AB and its competitors. This is 99% below median its historical median of 59.35. Over the past decade, Synthetic MR AB's Altman Z-Score has ranged from 0.59 to 163.41. According to the industry distribution chart, Synthetic MR AB ranks #526 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 79.7%.
Is Synthetic MR AB's Altman Z-Score too high?
Synthetic MR AB's current Altman Z-Score of 0.60 is 99% below median its 10-year median of 59.35. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 163.41. The Healthcare Providers & Services industry median Altman Z-Score is 2.45. Synthetic MR AB's value of 0.60 is 75.5% below this industry median. Based on the distribution chart, Synthetic MR AB ranks #526 out of 660 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Synthetic MR AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's Altman Z-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Synthetic MR AB ranks #526 out of 660 companies for Altman Z-Score. This places Synthetic MR AB in the lower half of its industry. The industry median Altman Z-Score is 2.45. Synthetic MR AB's value of 0.60 is 75.5% below this benchmark. Historically, Synthetic MR AB's own Altman Z-Score has ranged from 0.59 to 163.41 over the past decade. While the company's 10-year median is 59.35 vs. the industry median of 2.45, Synthetic MR AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.45, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synthetic MR AB's current Altman Z-Score of 0.60 is 75.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Synthetic MR AB and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthetic MR AB's current Altman Z-Score is 0.60, which is 99% below median its own 10-year median of 59.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Based on GuruFocus' analysis, Synthetic MR AB (XSAT:SYNT) is currently considered Possible Value Trap. The stock's GF Value™ is kr4.59, compared to a current price of kr0.62 — trading 86.6% below its estimated fair value. The current Altman Z-Score is 0.60, which is 99% below median its 10-year median of 59.35 and 75.5% below the Healthcare Providers & Services industry median of 2.45. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Synthetic MR AB (XSAT:SYNT), the current Altman Z-Score is 0.60 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synthetic MR AB (XSAT:SYNT) Overvalued in 2026?
Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued.
The current stock price of kr0.62 is trading 86.6% below its estimated GF Value™ of kr4.59.
GuruFocus considers Synthetic MR AB to be Possible Value Trap.
Key valuation signals for XSAT:SYNT:
Altman Z-Score: 0.60 (99% below median its 10-year median of 59.35)
GF Value™: kr4.59 vs. price of kr0.62 (86.6% below fair value)
Industry Position: 75.5% below the Healthcare Providers & Services median (#526 of 660)
No single metric tells the full story. See the XSAT:SYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score
Get the complete analysis for XSAT:SYNT
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:SYNT has been successfully added to your 
